A BCRA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

European Journal of Cancer

Volumn 33, Issue 14, 1997, Pages 2390-2392

  Dorum A ^a   Moller P ^a   Kamsteeg, E J ^c   Scheffer, H ^c   Burton, M ^c   Heimdal, K R ^a   Maehle L O ^a   Hovig, E ^b   Trope C G ^b   Van Der Hout, A H ^c   Van Der Meulen, M A ^c   Buys, C H C M ^c   Te Meerman, G J ^c  

^a Institute of Medical Genetics   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

BRCA1; Familial breast cancers; Familial ovarian cancer; Haplotype analysis

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER FAMILY; CLINICAL ARTICLE; GENE MUTATION; HAPLOTYPE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; ADULT; AGED; BREAST TUMOR; FEMALE; FOUNDER EFFECT; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; OVARY TUMOR; PEDIGREE; PHENOTYPE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; PHENOTYPE;

EID: 0031424268     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00328-6     Document Type: Article

References (23)

1. Iselius L, Slack J, Littler M, Morton NE. Genetic epidemiology of the breast cancer in Britain. Ann Human Genet. 55:1991;151-159.
2. Williams WR, Anderson DE. Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees. Genet Epidemiol. 1:1984;7-20.
3. Miki Y, Swensen J, Shattruck-Eidens E, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
4. Wooster R, Neuhausen SL, Mangion J, et al. Localization of breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265, 2088-2090.
5. Sobol H, Birnbaum D, Eisinger F. Evidence for a third breast cancer susceptibility gene. Lancet. 44:1994;1151-1152.
6. Kerangueven F, Essioux L, Dib A, et al. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 1995, 10, 1023-1026.
7. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 273:1995;577-585.
8. Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Human Genet. 52:(4):1993;678-701.
9. Easton DF, Ford D, Bishop DT and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation-carriers. Am J Human Genet 1995, 56, 265-271.
10. Mulligan LM, Eng C, Attié T, et al. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 1994, 12, 2163-2167.
11. Fisher RA. The Genetical Theory of Nature Selection, 2nd edn. New York, Dover, 1958, 84-90.
12. Dørum A, Kristensen GB, Abeler VM, Tropé CG, Møller P. Early detection of familial ovarian cancer. Eur J Cancer. 32:1996;1645-1651.
13. Møller P, Mæhle L, Heimdal K, et al. Inherited breast carcinoma. Prospective findings in 1194 women at risk. Acta Oncol 1997, 1 (Suppl. 1), 8-11.
14. Neuhausen SL, Mazoyer S, Friedman L, et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996, 58, 271-280.
15. Hagervorst FBL, Cornelis RS, Van Vliet M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995, 10, 208-212.
16. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995, 11, 198-200.
17. Andersen TI, Børresen A-L, Møller P. A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Human Genet. 59:1996;486-487.
18. Johannsson O, Ostermeyer EA, Håkansson S, et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Humun Genet 1996, 58, 441-450.
19. Van der Meulen MA, Te Meerman GJ. Association and haplotype sharing due to Identity by Descent, with an application to genetic mapping. In Edwards JH, Pawlowitzki IH, Thompson E, eds. Genetic Mapping of Disease Genes. New York, Academic Press, 1997.
20. Goldgar DE, Reilly RR. A common BRCA1 mutation in the Ashkenazim. Nat Genet. 11:1995;113-114.
21. Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995, 11(4), 422-433.
22. Amos CI, Shaw GL, Tucker MA, Hartge P. Age at onset for familial ovarian cancer. JAMA 1992, 268, 1896-1899.
23. Eccles D, Marlow A, Royle G, Collins A, Morton NE. Genetic epidemiology of early onset breast cancer. J Med Genet. 31:1994;944-949.